XML 23 R30.htm IDEA: XBRL DOCUMENT v3.20.1
Transition period (Tables)
12 Months Ended
Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Condensed Financial Statements
The Company is presenting its consolidated financial statements for the three month period ended March 31, 2019. The following tables provide certain unaudited comparative financial information for the same period of the prior year.

Consolidated Statements of Income
(in thousands, except share and per share data)

 
Three months ended March 31,
 
 
 
(unaudited)
 
2019
 
2018
Net sales
$
66,141

 
$
65,920

Cost of sales
25,650

 
25,712

Gross profit
40,491

 
40,208

Selling, general and administrative expenses
37,324

 
36,234

Restructuring expenses
22,176

 

Operating income (loss)
(19,009
)
 
3,974

Other expense, net
(315
)
 
(888
)
Interest expense, net
(1,849
)
 
(1,963
)
Income (loss) before provision for income taxes
(21,173
)
 
1,123

Income tax benefit (provision)
3,259

 
(433
)
Net income (loss)
$
(17,914
)
 
$
690

Comprehensive income (loss)
$
(17,914
)
 
$
690

Net income (loss) per share:
 
 
 
Basic
$
(0.37
)
 
$
0.01

Diluted
$
(0.37
)
 
$
0.01

Weighted average shares outstanding:
 
 
 
Basic
48,022,926

 
46,435,560

Diluted
48,022,926

 
49,302,771


Consolidated Statements of Cash Flows
(in thousands)


 
Three months ended March 31,
 
 
 
(unaudited)
 
2019
 
2018
Cash flows from operating activities:
 
 
 
Net income (loss)
$
(17,914
)
 
$
690

Adjustments to reconcile net income (loss) to net cash provided by
   operating activities:
 
 
 

Depreciation and amortization
7,544

 
4,288

Restructuring loss
22,176

 

Stock-based compensation expense
3,683

 
3,640

Amortization of debt issuance costs and discount on debt
190

 
199

Deferred income taxes
(3,433
)
 
735

Other, net
242

 
142

Changes in operating assets and liabilities:
 

 
 

Accounts receivable
4,215

 
12,771

Inventories
2,561

 
951

Prepaid expenses and other assets
(1,732
)
 
(1,498
)
Accounts payable and accrued expenses
(6,021
)
 
(16,891
)
Other liabilities
(3,295
)
 
3

Net cash provided by operating activities
8,216

 
5,030

 
 
 
 
Cash flows from investing activities:
 

 
 

Purchase of property and equipment
(3,400
)
 
(2,667
)
Net cash used in investing activities
(3,400
)
 
(2,667
)
 
 
 
 
Cash flows from financing activities:
 

 
 

Proceeds from revolving line of credit

 
2,000

Repayment of revolving line of credit

 
(2,000
)
Repayment of long-term debt
(2,063
)
 
(2,063
)
Cash received from issuance of common stock
115

 
212

Other, net
(199
)
 
(97
)
Net cash used in financing activities
(2,147
)
 
(1,948
)
 
 
 
 
Net increase in cash and cash equivalents
2,669

 
415

Cash and cash equivalents - beginning of period
51,205

 
10,059

Cash and cash equivalents - end of period
$
53,874

 
$
10,474